06660.HK
AIM Vaccine Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.48
−6.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 1.90x
- P/E 2027E
- 0.95x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.58x
- Price / sales
- 1.54x
- Price / cash flow
- 13.21x
Enterprise value
- Enterprise value
- HKD 3.9B
- EV / sales
- 3.29x
- EV / EBITDA
- -101.25x
- EV / EBIT
- -17.30x
- Market cap
- HKD 1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026